Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

724
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
724
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

614
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
614
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

811
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
811
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

594
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
594
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

1.2K
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
1.2K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

490
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
490

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical explantation of transcatheter heart valves: A single institution experience.

JTCVS structural and endovascular·2026
Same author

Angina with non-obstructive coronary arteries and myocardial bridge: long-term outcomes of surgical unroofing.

European heart journal·2026
Same author

Complex Percutaneous Intervention and Intravascular Lithotripsy for Critical Cabrol Anastomotic Stenosis Jeopardizing Global Coronary Circulation.

JACC. Case reports·2026
Same author

A generalizable deep learning system for cardiac MRI.

Nature biomedical engineering·2026
Same author

Transcatheter Edge-to-Edge Repair Increases Annular Forces in <i>In Vitro</i> Whole Heart Preparations.

bioRxiv : the preprint server for biology·2026
Same author

Lessons Learned from the HVAD Post-Approval Study Registry: Implications for Investigating Future Ventricular Assist Device Technology.

Journal of cardiac failure·2026

Related Experiment Video

Updated: Apr 19, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.3K

Ventricular assist device implantation in the elderly.

William Hiesinger1, Jack H Boyd1, Y Joseph Woo1

  • 11 Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, USA ; 2 Division of Cardiothoracic Surgery, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA ; 3 Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA, USA.

Annals of Cardiothoracic Surgery
|December 17, 2014
PubMed
Summary

Mechanical circulatory support, including ventricular assist devices (VADs), offers benefits for elderly heart failure patients. Early intervention and continuous flow devices are particularly advantageous for this demographic.

Keywords:
Ventricular assist device (VAD)elderlyheart failuremechanical circulatory support

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.8K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K

Related Experiment Videos

Last Updated: Apr 19, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.3K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.8K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Geriatrics

Background:

  • Mechanical circulatory support (MCS) is increasingly viable for elderly heart failure patients due to advances in ventricular assist device (VAD) technology and management.
  • The aging population presents a growing demographic for advanced heart failure therapies.

Purpose of the Study:

  • To review the current literature on the efficacy and considerations of mechanical circulatory support in elderly heart failure patients.
  • To identify specific benefits and challenges associated with VADs in older individuals.

Main Methods:

  • A comprehensive literature review was conducted, encompassing all relevant studies without time or language restrictions.
  • References from selected studies were meticulously examined to identify additional pertinent citations.

Main Results:

  • Continuous flow ventricular assist devices (VADs) demonstrate particular benefits for elderly patients, aligning with broader trends in mechanical circulatory support.
  • Early intervention prior to cardiogenic shock is crucial for all patients, but especially paramount in older individuals.

Conclusions:

  • Refinements in patient selection, surgical techniques, and post-operative care are expected to enhance outcomes for elderly patients receiving MCS.
  • Absolute age may become a less critical factor in MCS decisions, though clear guidelines for its use in the elderly are still needed.